Skip to main content

Table 1 (abstract P013). The factors affecting the duration of remission

From: Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)

Variable

HR

95.0 % CI

p

Gender

0.973

0.545-1.738

0.927

Age of diagnosis

1.003

0.998-1.008

0.205

RF positivity

1.182

0.580-2.405

0.646

Anti-CCP positivity

1.028

0.868-1.219

0.748

High AFR value in first admission

0.774

0.441-1.357

0.375

Number of involved joints

1.014

0.974-1.056

0.489

Large joint involvement

0.584

0.210-1.623

0.302

Temporamandibular joint involvement

1.336

0.567-3.146

0.508

Cervical involvement

1.444

0.652-3.198

0.365

Accompanying diseases

0.751

0.399-1.412

0.374

Uveitis

0.624

0.268-1.451

0.273

Ä°ntra-articular injection

0.627

0.354-1.111

0.110

Use of Biyolojical drug

0.067

0.007-0.594

0.015

Systemic Steroid treatment

0.828

0.493-1.390

0.475

Duration of systemic steroid treatment

1.003

0.970-1.036

0.875

Amount of systemic steroid (mg/m2 )

1.000

1.000-1.000

0.865

Duration of MTX

0.976

0.964-0.988

0.000

Duration of Biyolojic drug treatment

0.971

0.956-0.986

0.000